Literature DB >> 22947092

ALiBERO: evolving a team of complementary pocket conformations rather than a single leader.

Manuel Rueda1, Max Totrov, Ruben Abagyan.   

Abstract

Docking and virtual screening (VS) reach maximum potential when the receptor displays the structural changes needed for accurate ligand binding. Unfortunately, these conformational changes are often poorly represented in experimental structures or homology models, debilitating their docking performance. Recently, we have shown that receptors optimized with our LiBERO method (Ligand-guided Backbone Ensemble Receptor Optimization) were able to better discriminate active ligands from inactives in flexible-ligand VS docking experiments. The LiBERO method relies on the use of ligand information for selecting the best performing individual pockets from ensembles derived from normal-mode analysis or Monte Carlo. Here we present ALiBERO, a new computational tool that has expanded the pocket selection from single to multiple, allowing for automatic iteration of the sampling-selection procedure. The selection of pockets is performed by a dual method that uses exhaustive combinatorial search plus individual addition of pockets, selecting only those that maximize the discrimination of known actives compounds from decoys. The resulting optimized pockets showed increased VS performance when later used in much larger unrelated test sets consisting of biologically active and inactive ligands. In this paper we will describe the design and implementation of the algorithm, using as a reference the human estrogen receptor alpha.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22947092      PMCID: PMC3478405          DOI: 10.1021/ci3001088

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  48 in total

Review 1.  Prediction of the binding energy for small molecules, peptides and proteins.

Authors:  M Schapira; M Totrov; R Abagyan
Journal:  J Mol Recognit       Date:  1999 May-Jun       Impact factor: 2.137

Review 2.  Implications of protein flexibility for drug discovery.

Authors:  Simon J Teague
Journal:  Nat Rev Drug Discov       Date:  2003-07       Impact factor: 84.694

Review 3.  Target flexibility in molecular recognition.

Authors:  J Andrew McCammon
Journal:  Biochim Biophys Acta       Date:  2005-09-12

4.  Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking.

Authors:  Sheng-You Huang; Xiaoqin Zou
Journal:  Proteins       Date:  2007-02-01

Review 5.  Flexible ligand docking to multiple receptor conformations: a practical alternative.

Authors:  Maxim Totrov; Ruben Abagyan
Journal:  Curr Opin Struct Biol       Date:  2008-02-25       Impact factor: 6.809

6.  Impact of plasticity and flexibility on docking results for cytochrome P450 2D6: a combined approach of molecular dynamics and ligand docking.

Authors:  Jozef Hritz; Anita de Ruiter; Chris Oostenbrink
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

7.  Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.

Authors:  Vsevolod Katritch; Kimberly A Reynolds; Vadim Cherezov; Michael A Hanson; Christopher B Roth; Mark Yeager; Ruben Abagyan
Journal:  J Mol Recognit       Date:  2009 Jul-Aug       Impact factor: 2.137

8.  Consistent improvement of cross-docking results using binding site ensembles generated with elastic network normal modes.

Authors:  Manuel Rueda; Giovanni Bottegoni; Ruben Abagyan
Journal:  J Chem Inf Model       Date:  2009-03       Impact factor: 4.956

9.  Pocketome: an encyclopedia of small-molecule binding sites in 4D.

Authors:  Irina Kufareva; Andrey V Ilatovskiy; Ruben Abagyan
Journal:  Nucleic Acids Res       Date:  2011-11-12       Impact factor: 16.971

10.  Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes.

Authors:  Chiara Bolcato; Claudia Cusan; Giorgia Pastorin; Giampiero Spalluto; Barbara Cacciari; Karl Norbert Klotz; Erika Morizzo; Stefano Moro
Journal:  Purinergic Signal       Date:  2007-07-25       Impact factor: 3.765

View more
  20 in total

Review 1.  Identifying ligands at orphan GPCRs: current status using structure-based approaches.

Authors:  Tony Ngo; Irina Kufareva; James Lj Coleman; Robert M Graham; Ruben Abagyan; Nicola J Smith
Journal:  Br J Pharmacol       Date:  2016-03-05       Impact factor: 8.739

2.  The second extracellular loop of the adenosine A1 receptor mediates activity of allosteric enhancers.

Authors:  Dylan P Kennedy; Fiona M McRobb; Susan A Leonhardt; Michael Purdy; Heidi Figler; Melissa A Marshall; Mahendra Chordia; Robert Figler; Joel Linden; Ruben Abagyan; Mark Yeager
Journal:  Mol Pharmacol       Date:  2013-11-11       Impact factor: 4.436

3.  Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor.

Authors:  Zhong Zheng; Xi-Ping Huang; Thomas J Mangano; Rodger Zou; Xin Chen; Saheem A Zaidi; Bryan L Roth; Raymond C Stevens; Vsevolod Katritch
Journal:  J Med Chem       Date:  2017-04-03       Impact factor: 7.446

4.  SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice.

Authors:  James Palacino; Susanne E Swalley; Cheng Song; Atwood K Cheung; Lei Shu; Xiaolu Zhang; Mailin Van Hoosear; Youngah Shin; Donovan N Chin; Caroline Gubser Keller; Martin Beibel; Nicole A Renaud; Thomas M Smith; Michael Salcius; Xiaoying Shi; Marc Hild; Rebecca Servais; Monish Jain; Lin Deng; Caroline Bullock; Michael McLellan; Sven Schuierer; Leo Murphy; Marcel J J Blommers; Cecile Blaustein; Frada Berenshteyn; Arnaud Lacoste; Jason R Thomas; Guglielmo Roma; Gregory A Michaud; Brian S Tseng; Jeffery A Porter; Vic E Myer; John A Tallarico; Lawrence G Hamann; Daniel Curtis; Mark C Fishman; William F Dietrich; Natalie A Dales; Rajeev Sivasankaran
Journal:  Nat Chem Biol       Date:  2015-06-01       Impact factor: 15.040

5.  In silico identification and pharmacological evaluation of novel endocrine disrupting chemicals that act via the ligand-binding domain of the estrogen receptor α.

Authors:  Fiona M McRobb; Irina Kufareva; Ruben Abagyan
Journal:  Toxicol Sci       Date:  2014-06-13       Impact factor: 4.849

6.  Novel K-Ras G12C Switch-II Covalent Binders Destabilize Ras and Accelerate Nucleotide Exchange.

Authors:  Chimno I Nnadi; Meredith L Jenkins; Daniel R Gentile; Leslie A Bateman; Daniel Zaidman; Trent E Balius; Daniel K Nomura; John E Burke; Kevan M Shokat; Nir London
Journal:  J Chem Inf Model       Date:  2018-01-31       Impact factor: 4.956

7.  The Development of Target-Specific Pose Filter Ensembles To Boost Ligand Enrichment for Structure-Based Virtual Screening.

Authors:  Jie Xia; Jui-Hua Hsieh; Huabin Hu; Song Wu; Xiang Simon Wang
Journal:  J Chem Inf Model       Date:  2017-06-01       Impact factor: 4.956

Review 8.  Modelling three-dimensional protein structures for applications in drug design.

Authors:  Tobias Schmidt; Andreas Bergner; Torsten Schwede
Journal:  Drug Discov Today       Date:  2013-11-08       Impact factor: 7.851

9.  DOCK 6: Impact of new features and current docking performance.

Authors:  William J Allen; Trent E Balius; Sudipto Mukherjee; Scott R Brozell; Demetri T Moustakas; P Therese Lang; David A Case; Irwin D Kuntz; Robert C Rizzo
Journal:  J Comput Chem       Date:  2015-06-05       Impact factor: 3.376

10.  Structure-based predictions of activity cliffs.

Authors:  Jarmila Husby; Giovanni Bottegoni; Irina Kufareva; Ruben Abagyan; Andrea Cavalli
Journal:  J Chem Inf Model       Date:  2015-05-11       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.